Advertisement

Recurrent Vulvovaginal Infections: Etiology, Diagnosis, Treatment and Management

  • Jatinder Singh
  • Namarta Kalia
  • Manpreet Kaur
Chapter

Abstract

Abnormal vaginal discharge is a representative attribute of vulvovaginal infections (VVI). Frequent episodes of these infections are referred to as recurrent VVI (RVVI). The most common types of RVVI are vulvovaginal candidiasis (VVC) and bacterial vaginosis (BV). These infections are a significant cause of HIV acquisition and reproductive morbidity and hence have become a leading public health concern. The disturbances in vaginal ecosystem are the key events in the development of these disease conditions. The development of RVVI has been shown to be influenced by various host-related and behavioural risk factors. Traditional techniques used for detection of RVVI pathogens are based on the physiological and morphological characteristics. However, precise recognition of different clinical isolates is often found lengthy and complex. Therefore, many automatic as well as manual systems have been developed for the rapid identification of these opportunistic pathogens, though some of these methods were found to have considerable sensitivity issues. These limitations have been addressed by the development of various molecular typing techniques, which permits the early detections of these pathogens. However, incomplete understanding of pathophysiology of RVVI is a significant hurdle in the development of optimal treatment and prevention approaches. This chapter provides a comprehensive compilation of the present status of knowledge regarding etiology, diagnosis, treatment and management of RVVI. Systematic investigations in this particular area can provide better understanding of RVVI, further contributing to novel target recognition for more proficient therapeutic advances against these clinically relevant infections.

Keywords

Antimycotics Anti-RVVI vaccines Mixed infections Molecular approaches Probiotics Vaginal microbiota 

Notes

Acknowledgements

The authors express their sincere gratitude to the University Grants Commission, New Delhi, Govt. of India for providing Ph.D. fellowship to Namarta Kalia.

References

  1. Ahmad A, Khan AU (2009) Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynaecol Reprod Biol 144:68–71CrossRefGoogle Scholar
  2. Ahmad S, Khan Z (2012) Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods. Indian J Med Microbiol 30:264PubMedCrossRefPubMedCentralGoogle Scholar
  3. Akinbiyi AA, Watson R, Feyi-Waboso P (2008) Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Arch Gynecol Obstet 278:463–466PubMedCrossRefPubMedCentralGoogle Scholar
  4. Amouri I, Sellami H, Borji N, Abbes S, Sellami A, Cheikhrouhou F et al (2011) Epidemiological survey of vulvovaginal candidosis in Sfax, Tunisia. Mycoses 54:e499–e505PubMedCrossRefPubMedCentralGoogle Scholar
  5. Amsel R, Totten PA, Spiegel CA, Chen KC, Eschenbach D, Holmes KK (1983) Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 74:14–22PubMedCrossRefPubMedCentralGoogle Scholar
  6. Antonio MA, Hawes SE, Hillier SL (1999) The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 180:1950–1956PubMedCrossRefPubMedCentralGoogle Scholar
  7. Ashcraft KA, Bonneau RH (2008) Psychological stress exacerbates primary vaginal herpes simplex virus type 1 (HSV-1) infection by impairing both innate and adaptive immune responses. Brain Behav Immun 22:1231–1240PubMedPubMedCentralCrossRefGoogle Scholar
  8. Aslam M, Hafeez R, Ijaz S (2017) Vulvovaginal candidiasis in pregnancy. Biomedica 24:54–56Google Scholar
  9. Atashili J, Poole C, Ndumbe PM, Adimora AA, Smith JS (2008) Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS 22:1493–1501.  https://doi.org/10.1097/QAD.0b013e3283021a37 CrossRefPubMedPubMedCentralGoogle Scholar
  10. Auler ME, Morreira D, Rodrigues FF, Abr Ão MS, Margarido PF, Matsumoto FE et al (2010) Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis. Med Mycol 48:211–216PubMedCrossRefPubMedCentralGoogle Scholar
  11. Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P (1990) Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis 17:23–29PubMedCrossRefPubMedCentralGoogle Scholar
  12. Ball LM, Bes MA, Theelen B, Boekhout T, Egeler RM, Kuijper EJ (2004) Significance of amplified fragment length polymorphism in identification and epidemiological examination of Candida species colonization in children undergoing allogeneic stem cell transplantation. J Clin Microbiol 42:1673–1679PubMedPubMedCentralCrossRefGoogle Scholar
  13. Baloḡlu E, Özyazıcı M, Baloḡlu A, Ova L (2003) A randomized controlled trial of a new ovule formulation of ornidazole for the treatment of bacterial vaginosis. J Clin Pharm Ther 28:131–136PubMedCrossRefPubMedCentralGoogle Scholar
  14. Baruah FK, Sharma A, Das C, Hazarika NK, Agarwalla R (2014) Prevalence and epidemiological correlates of bacterial vaginosis among nonpregnant females at a tertiary care centre in Assam, India. Ann Trop Med Public Health 7:91–95Google Scholar
  15. Bauters TG, Nelis HJ (2002) Comparison of chromogenic and fluorogenic membrane filtration methods for detection of four Candida species. J Clin Microbiol 40:1838–1839PubMedPubMedCentralCrossRefGoogle Scholar
  16. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernández-Rodríguez C (2003) Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 41:414–420PubMedPubMedCentralCrossRefGoogle Scholar
  17. Beverly ES, Chen HY, Wang QJ, Zariffard MR, Cohen MH, Spear GT (2005) Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women. J Clin Microbiol 43:4607–4612CrossRefGoogle Scholar
  18. Bhalla P, Chawla R, Garg S, Singh MM, Raina U, Bhalla R et al (2007) Prevalence of bacterial vaginosis among women in Delhi, India. Indian J Med Res 125:167–172PubMedPubMedCentralGoogle Scholar
  19. Boggess KA, Trevett TN, Madianos PN, Rabe L, Hillier SL, Beck J et al (2005) Use of DNA hybridization to detect vaginal pathogens associated with bacterial vaginosis among asymptomatic pregnant women. Am J Obstet Gynecol 193:752–756.  https://doi.org/10.1016/j.ajog.2005.01.068 CrossRefPubMedPubMedCentralGoogle Scholar
  20. Bohannon NJV (1998) Treatment of vulvovaginal candidiasis in patients with diabetes. Diabetes Care 21:451–456PubMedCrossRefPubMedCentralGoogle Scholar
  21. Boris S, Suárez JE, Vázquez F, Barbés C (1998) Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 66:1985–1989PubMedPubMedCentralGoogle Scholar
  22. Borst A, Theelen B, Reinders E, Boekhout T, Fluit AC, Savelkoul PHM (2003) Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis. J Clin Microbiol 41:1357–1362PubMedPubMedCentralCrossRefGoogle Scholar
  23. Bougnoux ME, Dupont C, Mateo J, Saulnier P, Faivre V, Payen D et al (1999) Serum is more suitable than whole blood for diagnosis of systemic candidiasis by nested PCR. J Clin Microbiol 37:925–930PubMedPubMedCentralGoogle Scholar
  24. Bougnoux ME, Morand S, d’Enfert C (2002) Usefulness of multilocus sequence typing for characterization of clinical isolates of Candida albicans. J Clin Microbiol 40:1290–1297PubMedPubMedCentralCrossRefGoogle Scholar
  25. Bradford LL, Ravel J, Bruno V (2013) Understanding vulvovaginal candidiasis through a community genomics approach. Curr Fungal Infect Rep 7:126–131CrossRefGoogle Scholar
  26. Bradway SD, Levine MJ (1993) “Germ tube test” Reynolds-Braude phenomenon. Crit Rev Oral Biol Med 4:293–299PubMedCrossRefPubMedCentralGoogle Scholar
  27. Brandt M, Abels C, May T, Lohmann K, Schmidts-Winkler I, Hoyme UB (2008) Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynaecol Reprod Biol 141:158–162CrossRefGoogle Scholar
  28. Brotman RM, He X, Gajer P, Fadrosh D, Sharma E, Mongodin EF et al (2014) Association between cigarette smoking and the vaginal microbiota: a pilot study. BMC Infect Dis 14:471PubMedPubMedCentralCrossRefGoogle Scholar
  29. Bumgarner R (2013) Overview of DNA microarrays: types, applications, and their future. Curr Potocols Mol Miol 22:1Google Scholar
  30. Campanha NH, Neppelenbroek KH, Spolidório DMP, Spolidorio LC, Pavarina AC (2005) Phenotypic methods and commercial systems for the discrimination between C. albicans and C. dubliniensis. Oral Dis 11:392–398PubMedCrossRefPubMedCentralGoogle Scholar
  31. Cartwright CP, Lembke BD, Ramachandran K, Body BA, Nye MB, Rivers CA, Schwebke JR (2013) Comparison of nucleic acid amplification assays with BD affirm VPIII for diagnosis of vaginitis in symptomatic women. J Clin Microbiol 51:3694–3699PubMedPubMedCentralCrossRefGoogle Scholar
  32. Cassone A (2013) Development of vaccines for Candida albicans: fighting a skilled transformer. Nat Rev Microbiol 11:884–891PubMedCrossRefPubMedCentralGoogle Scholar
  33. Cauci S, Di Santolo M, Casabellata G, Ryckman K, Williams SM, Guaschino S (2007) Association of interleukin-1b and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in nonpregnant Italian women. MHR: Basic Sci Reprod Med 13:243–250Google Scholar
  34. Centers for Disease Control and Prevention (2011) Sexually transmitted diseases treatment guidelines, 2010. Ann Emerg Med 58:67–68CrossRefGoogle Scholar
  35. Cetin M, Ocak S, Gungoren A, Ulvi Hakverdi A (2007) Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods. Scand J Infect Dis 39:584–588PubMedCrossRefPubMedCentralGoogle Scholar
  36. Cheng G, Yeater KM, Hoyer LL (2006) Cellular and molecular biology of Candida albicans estrogen response. Eukaryot Cell 5:180–191PubMedPubMedCentralCrossRefGoogle Scholar
  37. Chiaffarino F, Parazzini F, De Besi P, Lavezzari M (2004) Risk factors for bacterial vaginosis. Eur J Obstet Gynecol Reprod Biol 117:222–226PubMedCrossRefPubMedCentralGoogle Scholar
  38. Cotch MF, Hillier SL, Gibbs RS, Eschenbach DA, Prematurity Study Group (1998) Epidemiology and outcomes associated with moderate to heavy Candida colonization during pregnancy. Am J Obstet Gynaecol 178:374–380CrossRefGoogle Scholar
  39. Culhane JF, Rauh V, McCollum KF, Hogan VK, Agnew K, Wadhwa PD (2001) Maternal stress is associated with bacterial vaginosis in human pregnancy. Matern Child Health J 5:127–134PubMedCrossRefPubMedCentralGoogle Scholar
  40. Cunningham FE, Kraus DM, Brubaker L, Fischer JH (1994) Pharmacokinetics of intravaginal metronidazole gel. J Clin Pharmacol 34:1060–1065PubMedCrossRefPubMedCentralGoogle Scholar
  41. Cutler JE, Deepe GS Jr, Klein BS (2007) Advances in combating fungal diseases: vaccines on the threshold. Nat Rev Microbiol 5:13–28PubMedCrossRefPubMedCentralGoogle Scholar
  42. Davies S, Johnson E, White D (2013) How to treat persistent vaginal yeast infection due to species other than Candida albicans. Sex Transm Infect 89:165–166PubMedCrossRefPubMedCentralGoogle Scholar
  43. De Leon EM, Jacober SJ, Sobel JD, Foxman B (2002) Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes. BMC Infect Dis 2:1PubMedPubMedCentralCrossRefGoogle Scholar
  44. Dennerstein GJ, Ellis DH (2001) Oestrogen, glycogen and vaginal candidiasis. Aust N Z J Obstet Gynaecol 41:326–328PubMedCrossRefPubMedCentralGoogle Scholar
  45. Dhabhar FS (2014) Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res 58:193–210PubMedCrossRefPubMedCentralGoogle Scholar
  46. Dhiman N, Hall L, Wohlfiel SL, Buckwalter SP, Wengenack NL (2011) Performance and cost analysis of matrix-assisted laser desorption ionization–time of flight mass spectrometry for routine identification of yeast. J Clin Microbiol 49:1614–1616PubMedPubMedCentralCrossRefGoogle Scholar
  47. Dols JA, Smit PW, Kort R, Reid G, Schuren FH, Tempelman H et al (2011) Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am J Obstet Gynaecol 204:305–3e1CrossRefGoogle Scholar
  48. Donders GG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B (2002) Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG Int J Obstet Gynaecol 109:34–43CrossRefGoogle Scholar
  49. Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R et al (2008) Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Am J Obstet Gynaecol 199:613–619CrossRefGoogle Scholar
  50. Donders GG, Ruban K, Bellen G (2015) Selecting anti-microbial treatment of aerobic vaginitis. Curr Infect Dis Rep 17:24.  https://doi.org/10.1007/s11908-015-0477-6 CrossRefGoogle Scholar
  51. Egbe CA, Onwufor UC, Omoregie R, Enabulele OI (2011) Female reproductive tract infections among vaginal contraceptive users in Benin City, Nigeria. Genom Med Biomark Health Sci 3:49–52CrossRefGoogle Scholar
  52. Elie CM, Lott TJ, Reiss E, Morrison CJ (1998) Rapid identification of Candida species with species-specific DNA probes. J Clin Microbiol 36:3260–3265PubMedPubMedCentralGoogle Scholar
  53. Esber A, Vicetti Miguel RD, Cherpes TL, Klebanoff MA, Gallo MF, Turner AN (2015) Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis. J Infect Dis 212:8–17PubMedCrossRefPubMedCentralGoogle Scholar
  54. Espinel-Ingroff A, Vazquez JA, Boikov D, Pfaller MA (1999) Evaluation of DNA-based typing procedures for strain categorization of Candida spp. Diagn Microbiol Infect Dis 33:231–239PubMedCrossRefPubMedCentralGoogle Scholar
  55. Falagas ME, Betsi GI, Athanasiou S (2006) Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 58:266–272PubMedCrossRefPubMedCentralGoogle Scholar
  56. Fan S, Liu X, Wu C, Xu L, Li J (2015) Vaginal nystatin versus oral fluconazole for the treatment for recurrent vulvovaginal candidiasis. Mycopathologia 179:95–101PubMedCrossRefPubMedCentralGoogle Scholar
  57. Fang X, Li H, Diao Y, Shan R, Dong J, Li H et al (2010) Polymorphisms in the MTHRF, VDR, MMP-9 and IL-β genes and the risk of premature rupture of membranes. Gynecol Obstet Investig 70:206–214CrossRefGoogle Scholar
  58. Fettweis JM, Serrano MG, Huang B, Brooks JP, Glascock AL, Sheth NU et al (2014) An emerging mycoplasma associated with trichomoniasis, vaginal infection and disease. PLoS One 9:e110943.  https://doi.org/10.1371/journal.pone.0110943 CrossRefPubMedPubMedCentralGoogle Scholar
  59. Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM (2007) Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol 45:3270–3276PubMedPubMedCentralCrossRefGoogle Scholar
  60. Fricke S, Fricke C, Schimmelpfennig C, Oelkrug C, Schönfelder U, Blatz R et al (2010) A real time PCR assay for the differentiation of Candida species. J Appl Microbiol 109:1150–1158PubMedCrossRefPubMedCentralGoogle Scholar
  61. Geiger AM, Foxman B (1996) Risk factors for vulvovaginal candidiasis: a case-control study among university students. Epidemiology 7:182–187PubMedCrossRefPubMedCentralGoogle Scholar
  62. Gibbs RS (1987) Microbiology of the female genital tract. Am J Obstet Gynecol 156:491–495PubMedCrossRefPubMedCentralGoogle Scholar
  63. Giraldo PC, Babula O, Gonçalves AKS, Linhares IM, Amaral RL, Ledger WJ et al (2007) Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstet Gynecol 109:1123–1128PubMedCrossRefPubMedCentralGoogle Scholar
  64. Goepfert AR, Varner M, Ward K, Macpherson C, Klebanoff M, Goldenberg RL et al (2005) Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy. Am J Obstet Gynaecol 193:1478–1485CrossRefGoogle Scholar
  65. Goldenberg RL, Klebanoff MA, Nugent R, Krohn MA, Hillier S, Andrews WW (1996) Bacterial colonization of the vagina during pregnancy in four ethnic groups. Am J Obstet Gynaecol 174:1618–1621CrossRefGoogle Scholar
  66. Gómez LM, Sammel MD, Appleby DH, Elovitz MA, Baldwin DA, Jeffcoat MK et al (2010) Evidence of a gene-environment interaction that predisposes to spontaneous preterm birth: a role for asymptomatic bacterial vaginosis and DNA variants in genes that control the inflammatory response. Am J Obstet Gynecol 202:386-e1.  https://doi.org/10.1016/j.ajog.2010.01.042 CrossRefGoogle Scholar
  67. Goswami D, Goswami R, Banerjee U, Dadhwal V, Miglani S, Lattif AA et al (2006) Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy. J Infect 52:111–117PubMedCrossRefPubMedCentralGoogle Scholar
  68. Gravitt PE, Hildesheim A, Herrero R, Schiffman M, Sherman ME, Bratti MC et al (2003) Correlates of IL-10 and IL-12 concentrations in cervical secretions. J Clin Immunol 23:175–183PubMedCrossRefPubMedCentralGoogle Scholar
  69. Greaves WL, Chungafung J, Morris B, Haile A, Townsend JL (1988) Clindamycin versus metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 72:799–802PubMedPubMedCentralGoogle Scholar
  70. Grigoriou O, Baka S, Makrakis E, Hassiakos D, Kapparos G, Kouskouni E (2006) Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors. Eur J Obstet Gynaecol Reprod Biol 126:121–125CrossRefGoogle Scholar
  71. Guaschino S, De Seta F, Sartore A, Ricci G, De Santo D, Piccoli M, Alberico S (2001) Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis. Am J Obstet Gynaecol 184:598–602CrossRefGoogle Scholar
  72. Gunther LSA, Martins HPR, Gimenes F, Abreu ALPD, Consolaro MEL, Svidzinski TIE (2014) Prevalence of Candida albicans and non-albicans isolates from vaginal secretions: comparative evaluation of colonization, vaginal candidiasis and recurrent vaginal candidiasis in diabetic and non-diabetic women. Sao Paulo Med J 132:116–120PubMedCrossRefPubMedCentralGoogle Scholar
  73. Gutierrez J, Morales P, Gonzalez MA, Quindos G (2002) Candida dubliniensis, a new fungal pathogen. J Basic Microbiol 42:207–227PubMedCrossRefPubMedCentralGoogle Scholar
  74. Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC (2011) Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species. Med Mycol 49:16–25PubMedCrossRefPubMedCentralGoogle Scholar
  75. Hamad M, Kazandji N, Awadallah S, Allam H (2014) Prevalence and epidemiological characteristics of vaginal candidiasis in the UAE. Mycoses 57:184–190PubMedCrossRefPubMedCentralGoogle Scholar
  76. Hanson JM, McGregor JA, Hillier SL, Eschenbach DA, Kreutner AK, Galask RP et al (2000) Metronidazole for bacterial vaginosis. A comparison of vaginal gel vs. oral therapy. J Reprod Med 45:889–896PubMedPubMedCentralGoogle Scholar
  77. Harriott MM, Lilly EA, Rodriguez TE, Fidel PL Jr, Noverr MC (2010) Candida albicans forms biofilms on the vaginal mucosa. Microbiology 156:3635–3644PubMedPubMedCentralCrossRefGoogle Scholar
  78. Hawes SE, Hillier SL, Benedetti J, Stevens CE, Koutsky LA, Wølner-Hanssen P et al (1996) Hydrogen peroxide – producing lactobacilli and acquisition of vaginal infections. J Infect Dis 174:1058–1063PubMedCrossRefPubMedCentralGoogle Scholar
  79. Hedayati MT, Taheri Z, Galinimoghadam T, Aghili SR, Cherati JY, Mosayebi E (2015) Isolation of different species of Candida in patients with vulvovaginal candidiasis from Sari, Iran. Jundishapur J Microbiol 8:e15992.  https://doi.org/10.5812/jjm.82015.15992 CrossRefPubMedPubMedCentralGoogle Scholar
  80. Heikkinen J, Vuopala S (1989) Anaerobic vaginosis: treatment with tinidazole vaginal tablets. Gynecol Obstet Investig 28:98–100CrossRefGoogle Scholar
  81. Held J, Kohlberger I, Rappold E, Grawitz AB, Häcker G (2013) Comparison of (1→ 3)-β-D-glucan, mannan/anti-mannan-antibodies and Cand-Tec Candida-antigen as serum biomarkers for Candidemia. J Clin Microbiol 51:1158–1164PubMedPubMedCentralCrossRefGoogle Scholar
  82. Holland J, Young ML, Lee O, Chen SC (2003) Vulvovaginal carriage of yeasts other than Candida albicans. Sex Transm Infect 79:249–250PubMedPubMedCentralCrossRefGoogle Scholar
  83. Horvath LL, Hospenthal DR, Murray CK, Dooley DP (2003) Direct isolation of Candida spp. from blood cultures on the chromogenic medium CHROMagar Candida. J Clin Microbiol 41:2629–2632PubMedPubMedCentralCrossRefGoogle Scholar
  84. Hostetter MK, Lorenz JS, Preus L, Kendrick KE (1990) The iC3b receptor on Candida albicans: subcellular localization and modulation of receptor expression by glucose. J Infect Dis 161:761–768PubMedCrossRefPubMedCentralGoogle Scholar
  85. Ison CA, Hay PE (2002) Validation of a simplified grading of gram stained vaginal smears for use in genitourinary medicine clinics. Sex Transm Infect 78:413–415PubMedPubMedCentralCrossRefGoogle Scholar
  86. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C (1995) Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J Antimicrob Chemother 35:103–114PubMedCrossRefPubMedCentralGoogle Scholar
  87. Jonsson M, Karlsson R, Rylander E, Gustavsson A, Wadell G (1997) The associations between risk behaviour and reported history of sexually transmitted diseases, among young women: a population-based study. Int J STD AIDS 8(8):501–505CrossRefGoogle Scholar
  88. Kalia N, Singh J, Sharma S, Kamboj SS, Arora H, Kaur M (2015) Prevalence of vulvovaginal infections and species specific distribution of vulvovaginal candidiasis in married women of North India. Int J Curr Microbiol App Sci 4:253–266Google Scholar
  89. Kalia N, Singh J, Sharma S, Arora H, Kaur M (2017) Genetic and phenotypic screening of mannosebinding lectin in relation to risk of recurrent vulvovaginal infections in women of North India: a prospective cohort study. Front Microbiol 8:75Google Scholar
  90. Kalia N, Kaur M, Sharma S, Singh J (2018) A comprehensive in Silico analysis of regulatory SNPs of human CLEC7A gene and its validation as genotypic and phenotypic disease marker in recurrent vulvovaginal infections. Front Cell Infect Microbiol 8:65Google Scholar
  91. Kalo-Klein A, Witkin SS (1991) Regulation of the immune response to Candida albicans monocytes and progesterone. Am J Obstet Gynecol 164:1351–1354PubMedCrossRefPubMedCentralGoogle Scholar
  92. Kamath P, Pais M, Nayak MG (2013) Risk of vaginal candidiasis among pregnant women. Int J Curr Microbiol App Sci 2:141–146Google Scholar
  93. Kanbe T, Horii T, Arishima T, Ozeki M, Kikuchi A (2002) PCR based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes. Yeast 19:973–989PubMedCrossRefPubMedCentralGoogle Scholar
  94. Kennedy MA, Sobel JD (2010) Vulvovaginal candidiasis caused by non-albicans Candida species: new insights. Curr Infect Dis Rep 12:465–470PubMedCrossRefPubMedCentralGoogle Scholar
  95. Krasnopolsky VN, Prilepskaya VN, Polatti F, Zarochentseva NV, Bayramova GR, Caserini M et al (2013) Efficacy of vitamin C vaginal tablets as prophylaxis for recurrent bacterial vaginosis: a randomised, double-blind, placebo-controlled clinical trial. J Clin Med Res 5:309–315PubMedPubMedCentralGoogle Scholar
  96. Larsson PG, Stray-Pedersen B, Ryttig KR, Larsen S (2008) Human lactobacilli as supplementation of clindamycin to patients with bacterial vaginosis reduce the recurrence rate; a 6-month, double-blind, randomized, placebo-controlled study. BMC Womens Health 8:3.  https://doi.org/10.1186/1472-6874-8-3 CrossRefPubMedPubMedCentralGoogle Scholar
  97. Lau A, Sorrell TC, Chen S, Stanley K, Iredell J, Halliday C (2008) Multiplex tandem PCR: a novel platform for rapid detection and identification of fungal pathogens from blood culture specimens. J Clin Microbiol 46:3021–3027PubMedPubMedCentralCrossRefGoogle Scholar
  98. Lazar E, Varga R (2011) Gynevac-a vaccine, containing lactobacillus for therapy and prevention of bacterial vaginosis and related diseases. Akush Ginekol 50:36–42Google Scholar
  99. Lieberman JA, Moscicki AB, Sumerel JL, Ma Y, Scott ME (2008) Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vaccine Immunol 15:49–54PubMedCrossRefPubMedCentralGoogle Scholar
  100. Liu MB, Xu SR, He Y, Deng GH, Sheng HF, Huang XM et al (2013) Diverse vaginal microbiomes in reproductive-age women with vulvovaginal candidiasis. PLoS One 8:e79812.  https://doi.org/10.1371/journal.pone.0079812 CrossRefPubMedPubMedCentralGoogle Scholar
  101. Livengood IIICH, Ferris DG, Wiesenfeld HC, Hillier SL, Soper DE, Nyirjesy P et al (2007) Effectiveness of two tinidazole regimens in treatment of bacterial vaginosis: a randomized controlled trial. Obstet Gynecol 110:302–309PubMedCrossRefPubMedCentralGoogle Scholar
  102. Lo HJ, Köhler JR, DiDomenico B, Loebenberg D, Cacciapuoti A, Fink GR (1997) Nonfilamentous C. albicans mutants are avirulent. Cell 90:939–949PubMedCrossRefPubMedCentralGoogle Scholar
  103. Lowe NK, Neal JL, Ryan-Wenger NA (2009) Accuracy of the clinical diagnosis of vaginitis compared to a DNA probe laboratory standard. Obstet Gynaecol 113:89CrossRefGoogle Scholar
  104. Luo G, Mitchell TG (2002) Rapid identification of pathogenic fungi directly from cultures by using multiplex PCR. J Clin Microbiol 40:2860–2865PubMedPubMedCentralCrossRefGoogle Scholar
  105. Mayer FL, Wilson D, Hube B (2013) Candida albicans pathogenicity mechanisms. Virulence 4:119–128PubMedPubMedCentralCrossRefGoogle Scholar
  106. McGroarty JA, Soboh F, Bruce AW, Reid G (1990) The spermicidal compound nonoxynol-9 increases adhesion of Candida species to human epithelial cells in vitro. Infect Immun 58:2005–2007PubMedPubMedCentralGoogle Scholar
  107. Menard JP, Fenollar F, Henry M, Bretelle F, Raoult D (2008) Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin Infect Dis 47:33–43PubMedCrossRefPubMedCentralGoogle Scholar
  108. Merz WG, Connelly C, Hieter P (1988) Variation of electrophoretic karyotypes among clinical isolates of Candida albicans. J Clin Microbiol 26:842–845PubMedPubMedCentralGoogle Scholar
  109. Mikamo H, Kawazoe K, Izumi K, Watanabe K, Ueno K, Tamaya T (1997) Comparative study on vaginal or oral treatment of bacterial vaginosis. Chemotherapy 43:60–68PubMedCrossRefPubMedCentralGoogle Scholar
  110. Mikulska M, Furfaro E, Del Bono V, Raiola AM, Ratto S, Bacigalupo A et al (2012) Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible for false-positive results of the galactomannan assay. J Antimicrob Chemother 67:1746–1748PubMedCrossRefPubMedCentralGoogle Scholar
  111. Milani M, Barcellona E, Agnello A (2003) Efficacy of the combination of 2 g oral tinidazole and acidic buffering vaginal gel in comparison with vaginal clindamycin alone in bacterial vaginosis: a randomized, investigator-blinded, controlled trial. Eur J Obstet Gynaecol Reprod Biol 109:67–71CrossRefGoogle Scholar
  112. Moreno SN, Docampo R (1985) Mechanism of toxicity of nitro compounds used in the chemotherapy of trichomoniasis. Environ Health Perspect 64:199–208PubMedPubMedCentralCrossRefGoogle Scholar
  113. Morris MC, Rogers PA, Kinghorn GR (2001) Is bacterial vaginosis a sexually transmitted infection? Sex Transm Infect 77:63–68PubMedPubMedCentralCrossRefGoogle Scholar
  114. Neerja J, Aruna A, Paramjeet G (2006) Significance of Candida culture in women with vulvovaginal symptoms. J Obstet Gynecol India 56:139–141Google Scholar
  115. Nelson DB, Macones G (2002) Bacterial vaginosis in pregnancy: current findings and future directions. Epidemiol Rev 24:102–108PubMedCrossRefPubMedCentralGoogle Scholar
  116. Nelson M, Wanjiru W, Margaret MW (2013) Prevalence of vaginal candidiasis and determination of the occurrence of Candida species in pregnant women attending the antenatal clinic of Thika District Hospital, Kenya. Open J Med Microbiol 3:264–274CrossRefGoogle Scholar
  117. Ness RB, Hillier S, Richter HE, Soper DE, Stamm C, Bass DC et al (2003) Can known risk factors explain racial differences in the occurrence of bacterial vaginosis? J Natl Med Assoc 95:201–212PubMedPubMedCentralGoogle Scholar
  118. Neves NA, Carvalho LP, De Oliveira MAM, Giraldo PC, Bacellar O, Cruz AA et al (2005) Association between atopy and recurrent vaginal candidiasis. Clin Exp Immunol 142:167–171PubMedPubMedCentralCrossRefGoogle Scholar
  119. Nilsson U, Hellberg D, Shoubnikova M, Nilsson S, Mardh PA (1997) Sexual behavior risk factors associated with bacterial vaginosis and Chlamydia trachomatis infection. Sex Transm Dis 24:241–246PubMedCrossRefPubMedCentralGoogle Scholar
  120. Nohmi T, Abe S, Dobashi K, Tansho S, Yamaguchi H (1995) Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women’s vulnerability to vaginal candidiasis. Microbiol Immunol 39:405–409PubMedCrossRefPubMedCentralGoogle Scholar
  121. North BB (1988) Vaginal contraceptives. Effective protection from sexually transmitted diseases for women? J Reprod Med 33:307–311PubMedPubMedCentralGoogle Scholar
  122. Nugent RP, Krohn MA, Hillier SL (1991) Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol 29:297–301PubMedPubMedCentralGoogle Scholar
  123. Núñez JT, Gómez G (2005) Low-dose secnidazole in the treatment of bacterial vaginosis. Int J Gynecol Obstet 88:281–285CrossRefGoogle Scholar
  124. Nwadioha SI, Egah DZ, Alao OO, Iheanacho E (2010) Risk factors for vaginal candidiasis among women attending primary health care centres in Jos, Nigeria. J Clin Med Res 2:111–113Google Scholar
  125. Odds F (1991) Sabouraud(s) agar. J Med Vet Mycol 29:355–359PubMedCrossRefPubMedCentralGoogle Scholar
  126. Okkers DJ, Dicks LMT, Silvester M, Joubert JJ, Odendaal HJ (1999) Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans. J Appl Microbiol 87:726–734PubMedCrossRefPubMedCentralGoogle Scholar
  127. Oliveira FA, Pfleger V, Lang K, Heukelbach J, Miralles I, Fraga F et al (2007) Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural Northeast Brazil: a population-based study. Mem Inst Oswaldo Cruz 102:751–756PubMedCrossRefPubMedCentralGoogle Scholar
  128. Onderdonk AB, Delaney ML, Fichorova RN (2016) The human microbiome during bacterial vaginosis. Clin Microbiol Rev 29:223–238PubMedPubMedCentralCrossRefGoogle Scholar
  129. Ozkinay E, Terek MC, Yayci M, Kaiser R, Grob P, Tuncay G (2005) The effectiveness of live lactobacilli in combination with low dose oestriol (Gynoflor) to restore the vaginal flora after treatment of vaginal infections. BJOG Int J Obstet Gynaecol 112:234–240CrossRefGoogle Scholar
  130. Paavonen J, Mangioni C, Martin MA, Wajszczuk CP (2000) Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 96:256–260PubMedPubMedCentralGoogle Scholar
  131. Peer AK, Hoosen AA, Seedat MA, Van Den Ende J, Omar MA (1993) Vaginal yeast infections in diabetic women. S Afr Med J 83:727–729PubMedPubMedCentralGoogle Scholar
  132. Peters BM, Palmer GE, Nash AK, Lilly EA, Fidel PL, Noverr MC (2014) Fungal morphogenetic pathways are required for the hallmark inflammatory response during Candida Albicans vaginitis. Infect Immun 82:532–543PubMedPubMedCentralCrossRefGoogle Scholar
  133. Pietrella D, Pandey N, Gabrielli E, Pericolini E, Perito S, Kasper L et al (2013) Secreted aspartic proteases of Candida albicans activate the NLRP3 inflammasome. Eur J Immunol 43:679–692PubMedCrossRefPubMedCentralGoogle Scholar
  134. Pitsouni E, Iavazzo C, Falagas ME (2008) Itraconazole vs fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomized controlled trials. Am J Obstet Gynaecol 198:153–160CrossRefGoogle Scholar
  135. Plitt SS, Garfein RS, Gaydos CA, Strathdee SA, Sherman SG, Taha TE (2005) Prevalence and correlates of Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis infections, and bacterial vaginosis among a cohort of young injection drug users in Baltimore, Maryland. Sex Transm Dis 32:446–453PubMedCrossRefPubMedCentralGoogle Scholar
  136. Powell AM, Nyirjesy P (2014) Recurrent vulvovaginitis. Best Pract Res Clin Obstet Gynaecol 28:967–976PubMedCrossRefPubMedCentralGoogle Scholar
  137. Powell HL, Sand CA, Rennie RP (1998) Evaluation of CHROMagar Candida for presumptive identification of clinically important Candida species. Diagn Microbiol Infect Dis 32:201–204PubMedCrossRefPubMedCentralGoogle Scholar
  138. Ralph SG, Rutherford AJ, Wilson JD (1999) Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study. Br Med J 319:220–223CrossRefGoogle Scholar
  139. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL et al (2011) Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci 108:4680–4687PubMedCrossRefPubMedCentralGoogle Scholar
  140. Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P et al (2007) Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Diabetes Care 30:312–317PubMedCrossRefPubMedCentralGoogle Scholar
  141. Reef SE, Levine WC, McNeil MM, Fisher-Hoch S, Holmberg SD, Duerr A et al (1995) Treatment options for vulvovaginal candidiasis, 1993. Clin Infect Dis 20:S80–S90PubMedCrossRefPubMedCentralGoogle Scholar
  142. Rigby S, Procop GW, Haase G, Wilson D, Hall G, Kurtzman C et al (2002) Fluorescence in situ hybridization with peptide nucleic acid probes for rapid identification of Candida albicans directly from blood culture bottles. J Clin Microbiol 40:2182–2186PubMedPubMedCentralCrossRefGoogle Scholar
  143. Rodrigues CF, Silva S, Henriques M (2014) Candida glabrata: a review of its features and resistance. Eur J Clin Microbiol Infect Dis 33:673–688PubMedCrossRefPubMedCentralGoogle Scholar
  144. Rosentul D, Delsing C, Joosten LA, van der Meer JW, Kullberg BJ, Netea MG (2009) Polymorphism in innate immunity genes and susceptibility to recurrent vulvovaginal candidiasis. J Mycol Méd/J Med Mycol 19:191–196CrossRefGoogle Scholar
  145. Ryckman KK, Simhan HN, Krohn MA, Williams SM (2009) Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod 15:131–137PubMedPubMedCentralCrossRefGoogle Scholar
  146. Santoro N, Randolph JF (2011) Reproductive hormones and the menopause transition. Obstet Gynecol Clin 38:455–466PubMedPubMedCentralCrossRefGoogle Scholar
  147. Saville SP, Lazzell AL, Chaturvedi AK, Monteagudo C, Lopez-Ribot JL (2009) Efficacy of a genetically engineered Candida albicans tet-NRG1 strain as an experimental live attenuated vaccine against hematogenously disseminated candidiasis. Clin Vaccine Immunol 16:430–432PubMedPubMedCentralCrossRefGoogle Scholar
  148. Schabereiter-Gurtner C, Selitsch B, Rotter ML, Hirschl AM, Willinger B (2007) Development of novel real-time PCR assays for detection and differentiation of eleven medically important Aspergillus and Candida species in clinical specimens. J Clin Microbiol 45:906–914PubMedPubMedCentralCrossRefGoogle Scholar
  149. Schmidt CS, White CJ, Ibrahim AS, Filler SG, Fu Y, Yeaman MR et al (2012) NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30:7594–7600PubMedPubMedCentralCrossRefGoogle Scholar
  150. Schoofs A, Odds FC, Colebunders R, Ieven M, Goossens H (1997) Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis 16:296–300PubMedCrossRefPubMedCentralGoogle Scholar
  151. Schreiber CA, Meyn LA, Creinin MD, Barnhart KT, Hillier SL (2006) Effects of long-term use of nonoxynol-9 on vaginal flora. Obstet Gynaecol 107:136–143CrossRefGoogle Scholar
  152. Scott ME, Ma Y, Farhat S, Shiboski S, Moscicki AB (2006) Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol 26:222–232PubMedCrossRefPubMedCentralGoogle Scholar
  153. Seidman LS, Skokos CK (2005) An evaluation of butoconazole nitrate 2% site release® vaginal cream (Gynazole-1®) compared to fluconazole 150 mg tablets (Diflucan®) in the time to relief of symptoms in patients with vulvovaginal candidiasis. Infect Dis Obstet Gynaecol 13:197–206CrossRefGoogle Scholar
  154. Sharma M, Solanki A (2014) Prevalence of Candida infection in pregnant women with and without diabetes. Int J Curr Microbiol App Sci 3:605–610Google Scholar
  155. Shepard JR, Addison RM, Alexander BD, Della-Latta P, Gherna M, Haase G et al (2008) Multicenter evaluation of the Candida albicans/Candida glabrata peptide nucleic acid fluorescent in situ hybridization method for simultaneous dual-color identification of C. albicans and C. glabrata directly from blood culture bottles. J Clin Microbiol 46:50–55PubMedCrossRefPubMedCentralGoogle Scholar
  156. Sherrard J, Donders G, White D, Jensen JS (2011) European (IUSTI/WHO) guideline on the management of vaginal discharge, 2011. Int J STD AIDS 22:421–429PubMedCrossRefPubMedCentralGoogle Scholar
  157. Shoubnikova M, Hellberg D, Nilsson S, Mårdh PA (1997) Contraceptive use in women with bacterial vaginosis. Contraception 55:355–358PubMedCrossRefPubMedCentralGoogle Scholar
  158. Simhan HN, Caritis SN, Hillier SL, Krohn MA (2005) Cervical anti-inflammatory cytokine concentrations among first-trimester pregnant smokers. Am J Obstet Gynecol 193:1999–2003PubMedCrossRefPubMedCentralGoogle Scholar
  159. Singh S, Sobel JD, Bhargava P, Boikov D, Vazquez JA (2002) Vaginitis due to Candida krusei: epidemiology, clinical aspects, and therapy. Clin Infect Dis 35:1066–1070PubMedCrossRefPubMedCentralGoogle Scholar
  160. Sobel JD (1988) Pathogenesis and epidemiology of vulvovaginal candidiasis. Ann N Y Acad Sci 544:547–557PubMedCrossRefPubMedCentralGoogle Scholar
  161. Sobel JD (2006) Management of recurrent vulvovaginal candidiasis: unresolved issues. Curr Infect Dis Rep 8:481–486PubMedCrossRefPubMedCentralGoogle Scholar
  162. Sobel JD (2007) Vulvovaginal candidosis. Lancet 369:1961–1971PubMedCrossRefPubMedCentralGoogle Scholar
  163. Sobel JD (2014) Genital candidiasis. Medicine 38:186–190Google Scholar
  164. Sobel JD (2016) Recurrent vulvovaginal candidiasis. Am J Obstet Gynaecol 214:15–21CrossRefGoogle Scholar
  165. Sobel JD, Akins RA (2015) The role of PCR in the diagnosis of candida vulvovaginitis – a new gold standard? Curr Infect Dis Rep 17:488.  https://doi.org/10.1007/s11908-015-0488-3 CrossRefPubMedPubMedCentralGoogle Scholar
  166. Sobel JD, Chaim W, Nagappan V, Leaman D (2003) Treatment of vaginitis caused by Candida glabrata: use of topical boric acid and flucytosine. Am J Obstet Gynaecol 189:1297–1300CrossRefGoogle Scholar
  167. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A et al (2004) Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. N Engl J Med 351:876–883PubMedCrossRefPubMedCentralGoogle Scholar
  168. Sobel JD, Subramanian C, Foxman B, Fairfax M, Gygax SE (2013) Mixed vaginitis – more than coinfection and with therapeutic implications. Curr Infect Dis Rep 15:104–108PubMedCrossRefPubMedCentralGoogle Scholar
  169. Souza ACR, Ferreira RC, Gonçalves SS, Quindós G, Eraso E, Bizerra FC et al (2012) Accurate identification of Candida parapsilosis (sensu lato) by use of mitochondrial DNA and real-time PCR. J Clin Microbiol 50:2310–2314PubMedPubMedCentralCrossRefGoogle Scholar
  170. Špaček J, Buchta V, Jílek P, Förstl M (2007) Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. Eur J Obstet Gynecol Reprod Biol 131:198–202PubMedCrossRefPubMedCentralGoogle Scholar
  171. Spanu T, Posteraro B, Fiori B, D’Inzeo T, Campoli S, Ruggeri A et al (2012) Direct MALDI-TOF mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories. J Clin Microbiol 50:176–179PubMedPubMedCentralCrossRefGoogle Scholar
  172. Spiegel CA, Amsel R, Holmes KK (1983) Diagnosis of bacterial vaginosis by direct gram stain of vaginal fluid. J Clin Microbiol 18:170–177PubMedPubMedCentralGoogle Scholar
  173. Srinivasan S, Fredricks DN (2009) The human vaginal bacterial biota and bacterial vaginosis. Interdiscip Perspect Infect Dis 2008:750479.  https://doi.org/10.1155/2008/750479 CrossRefPubMedCentralGoogle Scholar
  174. Steffan P, Vazquez JA, Boikov D, Xu C, Sobel JD, Akins RA (1997) Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 35:2031–2039PubMedPubMedCentralGoogle Scholar
  175. Sullivan D, Coleman D (1998) Candida dubliniensis: characteristics and identification. J Clin Microbiol 36:329–334PubMedPubMedCentralGoogle Scholar
  176. Taylor BD, Darville T, Ferrell RE, Ness RB, Kelsey SF, Haggerty CL (2014) Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African–American women with pelvic inflammatory disease. Sex Transm Infect 90:563–566PubMedCrossRefPubMedCentralGoogle Scholar
  177. Toth B, Würfel W, Bohlmann MK, Gillessen-Kaesbach G, Nawroth F, Rogenhofer N et al (2015) Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013). Geburtshilfe Frauenheilkd 75:1117–1129PubMedPubMedCentralCrossRefGoogle Scholar
  178. Trost A, Graf B, Eucker J, Sezer O, Possinger K, Göbel UB et al (2004) Identification of clinically relevant yeasts by PCR/RFLP. J Microbiol Methods 56:201–211PubMedCrossRefPubMedCentralGoogle Scholar
  179. Trtkova J, Raclavsky V (2006) Molecular-genetic approaches to identification and typing of pathogenic Candida yeasts. Biomed Pap-Palacky Univ Olomouc 150:51–61CrossRefGoogle Scholar
  180. van de Wijgert JH, Borgdorff H, Verhelst R, Crucitti T, Francis S, Verstraelen H et al (2014) The vaginal microbiota: what have we learned after a decade of molecular characterization? PloS One 9:e105998.  https://doi.org/10.1371/journal.pone.0105998 CrossRefPubMedPubMedCentralGoogle Scholar
  181. Velraeds MM, Van de Belt-Gritter B, Van der Mei HC, Reid G, Busscher HJ (1998) Interference in initial adhesion of uropathogenic bacteria and yeasts to silicone rubber by a Lactobacillus acidophilus biosurfactant. J Med Microbiol 47:1081–1085PubMedCrossRefPubMedCentralGoogle Scholar
  182. Vermitsky JP, Self MJ, Chadwick SG, Trama JP, Adelson ME, Mordechai E et al (2008) Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection. J Clin Microbiol 46:1501–1503PubMedPubMedCentralCrossRefGoogle Scholar
  183. Verstraelen H, Verhelst R (2009) Bacterial vaginosis: an update on diagnosis and treatment. Expert Rev Anti-Infect Ther 7:1109–1124PubMedCrossRefPubMedCentralGoogle Scholar
  184. Vijaya D, Dhanalakshmi TA, Kulkarni S (2014) Changing trends of vulvovaginal candidiasis. J Lab Phys 6:28–30Google Scholar
  185. Vos P, Hogers R, Bleeker M, Reijans M, Lee TVD, Hornes M et al (1995) AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 23:4407–4414PubMedPubMedCentralCrossRefGoogle Scholar
  186. Vylkova S, Carman AJ, Danhof HA, Collette JR, Zhou H, Lorenz MC (2011) The fungal pathogen Candida albicans autoinduces hyphal morphogenesis by raising extracellular pH. MBio 2:e00055–e00011.  https://doi.org/10.1128/mBio.00055-11 CrossRefPubMedPubMedCentralGoogle Scholar
  187. Wang Y (2009) CDKs and the yeast-hyphal decision. Curr Opin Microbiol 12:644–649PubMedCrossRefPubMedCentralGoogle Scholar
  188. Wang FM, Qian XD, Xu H, Yu HY (2008) Efficacy of 5-nitroimidazole derivatives in treatment of bacterial vaginosis. Zhonghua Yi Xue Za Zhi 88:2201–2203PubMedPubMedCentralGoogle Scholar
  189. Warren D, Klein RS, Sobel J, Kieke B, Brown W, Schuman P et al (2001) A multicenter study of bacterial vaginosis in women with or at risk for human immunodeficiency virus infection. Infect Dis Obstet Gynaecol 9:133–141CrossRefGoogle Scholar
  190. Watson MC, Grimshaw JM, Bond CM, Mollison J, Ludbrook A (2002) Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review. BJOG Int J Obstet Gynaecol 109:85–95CrossRefGoogle Scholar
  191. Watts DH, Rabe L, Krohn MA, Aura J, Hillier SL (1999) The effects of three nonoxynol-9 preparations on vaginal flora and epithelium. J Infect Dis 180:426–437PubMedCrossRefPubMedCentralGoogle Scholar
  192. Weissenbacher T, Witkin SS, Ledger WJ, Tolbert V, Gingelmaier A, Scholz C et al (2009) Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction. Arch Gynaecol Obstet 279:125–129CrossRefGoogle Scholar
  193. Wilson J, Ralph S, Rutherford A (2000) Rates of bacterial vaginosis in women with different types of infertility. In: STD conference, Baltimore, MarylandGoogle Scholar
  194. Wira CR, Fahey JV (2008) A new strategy to understand how HIV infects women: identification of a window of vulnerability during the menstrual cycle. AIDS (London, England) 22:1909–1917CrossRefGoogle Scholar
  195. Wouters MM, Van Wanrooy S, Nguyen A, Dooley J, Aguilera-Lizarraga J, Van Brabant W et al (2016) Psychological comorbidity increases the risk for postinfectious IBS partly by enhanced susceptibility to develop infectious gastroenteritis. Gut 65:1279–1288PubMedCrossRefPubMedCentralGoogle Scholar
  196. Yoshimura K, Morotomi N, Fukuda K, Nakano M, Kashimura M, Hachisuga T et al (2011) Intravaginal microbial flora by the 16S rRNA gene sequencing. Am J Obstet Gynaecol 205:235-e1–235.e9.  https://doi.org/10.1016/j.ajog.2011.04.018 CrossRefGoogle Scholar
  197. Zeng J, Zong LL, Mao T, Huang YX, Xu ZM (2011) Distribution of Candida albican genotype and Candida species is associated with the severity of vulvovagianl candidiasis. Nan Fang Yi Ke Da Xue Xue Bao 31:1649–1653PubMedPubMedCentralGoogle Scholar
  198. Zhang X, Essmann M, Burt ET, Larsen B (2000) Estrogen effects on Candida albicans: a potential virulence-regulating mechanism. J Infect Dis 181:1441–1446PubMedCrossRefPubMedCentralGoogle Scholar
  199. Zozaya M, Ferris MJ, Siren JD, Lillis R, Myers L, Nsuami MJ et al (2016) Bacterial communities in penile skin, male urethra, and vaginas of heterosexual couples with and without bacterial vaginosis. Microbiome 4:16.  https://doi.org/10.1186/s40168-016-0161-6 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Jatinder Singh
    • 1
  • Namarta Kalia
    • 1
  • Manpreet Kaur
    • 2
  1. 1.Department of Molecular Biology and BiochemistryGuru Nanak Dev UniversityAmritsarIndia
  2. 2.Department of Human GeneticsGuru Nanak Dev UniversityAmritsarIndia

Personalised recommendations